Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor.

IF 3.2 2区 医学 Q2 CLINICAL NEUROLOGY
Journal of Neuro-Oncology Pub Date : 2025-06-01 Epub Date: 2025-03-05 DOI:10.1007/s11060-025-04991-5
Jawad Fares, Yizhou Wan, Binay Gurung, Thaaqib Nazar, Richard Mair, Alexis Joannides, Thomas Santarius, Tomasz Matys, Stephen J Price
{"title":"Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor.","authors":"Jawad Fares, Yizhou Wan, Binay Gurung, Thaaqib Nazar, Richard Mair, Alexis Joannides, Thomas Santarius, Tomasz Matys, Stephen J Price","doi":"10.1007/s11060-025-04991-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study investigated invasion patterns of temporal lobe glioblastoma following complete resection of contrast-enhancing tumor and evaluated whether non-enhancing tumor presence in the anterior temporal tip predicts the site of progression.</p><p><strong>Methods: </strong>We retrospectively analyzed patients from a single-institution database who were diagnosed with IDH-wildtype temporal lobe glioblastoma and underwent complete resection of the contrast-enhancing region. Eligible patients had preoperative, immediate postoperative, and progression MRIs to assess tumor progression patterns. FLAIR imaging was examined for its predictive value in identifying progression sites. Surgical outcomes, progression-free survival (PFS), and overall survival were analyzed.</p><p><strong>Results: </strong>A total of 48 patients were identified, of whom 14 (29%) underwent anterior temporal lobectomy and were excluded from further analysis. Among the remaining 34 patients, 21 (62%) exhibited anterior progression. Expert assessment suggested that in 12 of these 21 patients (57%), an anterior temporal lobectomy might have encompassed the region of tumor progression. Superior, inferior, and lateral progression patterns were associated with longer median PFS (~ 11 months), whereas medial progression correlated with the shortest PFS (5.9 months). FLAIR signal at the temporal tip had moderate sensitivity (71.43%) but low specificity (18.52%) for predicting anterior progression, resulting in a high false-positive rate.</p><p><strong>Conclusions: </strong>Temporal lobe glioblastomas often progress anteriorly, suggesting that anterior temporal lobectomy may help reduce progression in select cases. FLAIR imaging had limited predictive value for anterior progression, emphasizing the need for advanced imaging techniques. Future research should identify reliable biomarkers and evaluate the role of anterior temporal lobectomy through well-designed prospective studies.</p>","PeriodicalId":16425,"journal":{"name":"Journal of Neuro-Oncology","volume":" ","pages":"353-360"},"PeriodicalIF":3.2000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12106570/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neuro-Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11060-025-04991-5","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This study investigated invasion patterns of temporal lobe glioblastoma following complete resection of contrast-enhancing tumor and evaluated whether non-enhancing tumor presence in the anterior temporal tip predicts the site of progression.

Methods: We retrospectively analyzed patients from a single-institution database who were diagnosed with IDH-wildtype temporal lobe glioblastoma and underwent complete resection of the contrast-enhancing region. Eligible patients had preoperative, immediate postoperative, and progression MRIs to assess tumor progression patterns. FLAIR imaging was examined for its predictive value in identifying progression sites. Surgical outcomes, progression-free survival (PFS), and overall survival were analyzed.

Results: A total of 48 patients were identified, of whom 14 (29%) underwent anterior temporal lobectomy and were excluded from further analysis. Among the remaining 34 patients, 21 (62%) exhibited anterior progression. Expert assessment suggested that in 12 of these 21 patients (57%), an anterior temporal lobectomy might have encompassed the region of tumor progression. Superior, inferior, and lateral progression patterns were associated with longer median PFS (~ 11 months), whereas medial progression correlated with the shortest PFS (5.9 months). FLAIR signal at the temporal tip had moderate sensitivity (71.43%) but low specificity (18.52%) for predicting anterior progression, resulting in a high false-positive rate.

Conclusions: Temporal lobe glioblastomas often progress anteriorly, suggesting that anterior temporal lobectomy may help reduce progression in select cases. FLAIR imaging had limited predictive value for anterior progression, emphasizing the need for advanced imaging techniques. Future research should identify reliable biomarkers and evaluate the role of anterior temporal lobectomy through well-designed prospective studies.

对比增强肿瘤完全切除后颞叶胶质母细胞瘤的空间侵袭模式。
目的:本研究探讨对比增强肿瘤完全切除后颞叶胶质母细胞瘤的侵袭模式,并评估颞叶前尖端非增强肿瘤的存在是否能预测其进展部位。方法:我们回顾性分析了来自单一机构数据库的诊断为idh野生型颞叶胶质母细胞瘤并完全切除对比增强区域的患者。符合条件的患者术前、术后即刻和进展期mri评估肿瘤进展模式。研究了FLAIR成像在识别进展部位方面的预测价值。分析手术结果、无进展生存期(PFS)和总生存期。结果:共确定48例患者,其中14例(29%)接受了前颞叶切除术,并被排除在进一步分析之外。在其余34例患者中,21例(62%)表现为前路进展。专家评估表明,在这21例患者中,有12例(57%)的前颞叶切除术可能包含了肿瘤进展区域。上、下、外侧进展模式与较长的中位PFS(~ 11个月)相关,而内侧进展与最短的PFS(5.9个月)相关。颞尖FLAIR信号预测前路进展的敏感性中等(71.43%),特异性较低(18.52%),假阳性率较高。结论:颞叶胶质母细胞瘤通常向前发展,提示颞叶前部切除术可能有助于减少某些病例的进展。FLAIR成像对前路进展的预测价值有限,强调需要先进的成像技术。未来的研究应确定可靠的生物标志物,并通过精心设计的前瞻性研究评估前颞叶切除术的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Neuro-Oncology
Journal of Neuro-Oncology 医学-临床神经学
CiteScore
6.60
自引率
7.70%
发文量
277
审稿时长
3.3 months
期刊介绍: The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research. The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests. More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches. To alleviate having to scan dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信